Cargando…
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015975/ https://www.ncbi.nlm.nih.gov/pubmed/34878604 http://dx.doi.org/10.1007/s00432-021-03877-z |
| _version_ | 1784688428820987904 |
|---|---|
| author | Wang, Peiliang Yin, Tianwen Zhao, Kaikai Yu, Jinming Teng, Feifei |
| author_facet | Wang, Peiliang Yin, Tianwen Zhao, Kaikai Yu, Jinming Teng, Feifei |
| author_sort | Wang, Peiliang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9015975 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90159752022-05-02 Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer Wang, Peiliang Yin, Tianwen Zhao, Kaikai Yu, Jinming Teng, Feifei J Cancer Res Clin Oncol Correction Springer Berlin Heidelberg 2021-12-08 2022 /pmc/articles/PMC9015975/ /pubmed/34878604 http://dx.doi.org/10.1007/s00432-021-03877-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Wang, Peiliang Yin, Tianwen Zhao, Kaikai Yu, Jinming Teng, Feifei Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer |
| title | Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer |
| title_full | Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer |
| title_fullStr | Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer |
| title_full_unstemmed | Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer |
| title_short | Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer |
| title_sort | correction to: efficacy of single-site radiotherapy plus pd-1 inhibitors vs pd-1 inhibitors for oligometastatic non-small cell lung cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015975/ https://www.ncbi.nlm.nih.gov/pubmed/34878604 http://dx.doi.org/10.1007/s00432-021-03877-z |
| work_keys_str_mv | AT wangpeiliang correctiontoefficacyofsinglesiteradiotherapypluspd1inhibitorsvspd1inhibitorsforoligometastaticnonsmallcelllungcancer AT yintianwen correctiontoefficacyofsinglesiteradiotherapypluspd1inhibitorsvspd1inhibitorsforoligometastaticnonsmallcelllungcancer AT zhaokaikai correctiontoefficacyofsinglesiteradiotherapypluspd1inhibitorsvspd1inhibitorsforoligometastaticnonsmallcelllungcancer AT yujinming correctiontoefficacyofsinglesiteradiotherapypluspd1inhibitorsvspd1inhibitorsforoligometastaticnonsmallcelllungcancer AT tengfeifei correctiontoefficacyofsinglesiteradiotherapypluspd1inhibitorsvspd1inhibitorsforoligometastaticnonsmallcelllungcancer |